Dr. Meg Mooney of the National Cancer Institute discusses new initiatives to accelerate development of cancer therapies in the era of precision medicine.
Mr. Henry Ahn of the National Science Foundation speaks on the NSF’s SBIR and STTR programs.
The largest-ever gathering in the Australian life sciences!
International BioFest 2016 will be the largest-ever gathering in Australian life sciences, with three major conferences coming together in one week in one place as one integrated network. The event will be held from 24-27 October 2016 in Melbourne by AusBiotech.
Conferences include the 17th International Biotechnology Symposium (IBS 2016), presenting the most advanced topics in biotechnology, green chemistry and its related fields; AusBiotech 2016, Australia’s national life science conference; and Australia Biotech Invest, Australia’s life science investment showcase.
Delegates from the biotechnology, biopharmaceutical, life sciences, business, investment, research, academic and health sectors will gather to celebrate Australian and international life sciences and highlight Melbourne as one of the world’s great biotechnology hubs.
FreeMind Group to discuss alternative funding
Ayal Ronen, Vice President, FreeMind Group, will be part of the panel discussing alternative funding, discussing how this flexible funding model can be used within the life science sector. Mr Ronen will be joined by Bill Best, Managing Director, On Market Book Builds, and Ross Curtin, CEO, WealthSpring International Group.
Ayal Ronen, FreeMind’s Vice President, will be visiting the Research Triangle Park in North Carolina in late July and will be presenting at the NC Biotechnology Center‘s Hamner Conference Center on July 22.
Ayal will provide insight into the non-dilutive funding landscape with an emphasis on the NIH, DOD, and BARDA and will describe the various mechanisms and pockets of money available, potential for funding, and means to maximize chances for award.
There will also be an opportunity to meet with Ayal following the presentation where you can speak more directly about your specific organization and its funding needs. To schedule a 1×1, please email Irina.
This presentation is free and open to all, but registration is required.
Come hear Meytal provide insight into the non-dilutive funding landscape with an emphasis on the NIH, DOD, and BARDA, as she describes the various mechanisms and pockets of money available, potential for funding, means to maximize chances for award, and a special funding assistance for Pennsylvania organizations applying for SBIR/STTR grants.
Lunch will be provided and attendance is free, but registration is required.
Ram May-Ron and Ayal Ronen of the FreeMind Group introduce the R&DMoneyView, a tool that will allow its users to gain insight into non-dilutive Federal awards made to domestic, for-profit organizations to support R&D in the Life Sciences.
R&DMoneyView is the first tool in the R&DMoney suite of tools designed to streamline the granting process in a cost-efficient manner while maximizing chances for award.